|
Office of the Director
The Director of DPMCDA, Frank Vocci, Ph.D., provides leadership and direction to the varied activities of the Division’s programs. He is assisted in this endeavor by staff who coordinate the functional areas of the OD, DPMCDA. The Informatics Unit, residing in the OD, DPMCDA, designs, develops, integrates, supports, and provides information technology tools, customized applications, informatics support, bio-informatics programs, and support for scientific computing. The functional areas within the OD, DPMCDA provide policy and technology transfer guidance, program development and evaluation, and overall operational, administrative, and budgeting coordination for the Division. The OD, DPMCDA works closely with the OD, NIDA in establishing relationships with other Government agencies and health organizations, Congress, academia, and the private sector.
Office of the Director Personnel Contacts
Frank Vocci, Ph.D., Director
301-443-6173
fv6k@nih.gov
Provides leadership, programmatic oversight, and direction for all DPMCDA projects. Manages resources involved in the development of immunological and pharmacological approaches for the treatment of psychoactive substance disorders, primarily opiate and stimulant dependence disorders. Eleven years of research and review experience in the FDA. Joined NIDA Medications Development Program in 1989. Received a Presidential Award in 2001 from President Bush for the achievements of the NIDA Medications Program.
Richard Hawks, Ph.D., Deputy Director
301-443-6173
rhawks@nih.gov
In conjunction with the Director, provides programmatic oversight for DPMCDA projects and manages activities and resources of the Division involved in the development of medications for the treatment of opiate and stimulant dependence disorders. Administers Division research budget and planning processes. As former Chief of NIDA's Research Technology Branch, directed NIDA's Drug Supply Program and research programs in medicinal and analytical chemistry. As former Chief of DPMCDA's Chemistry and Pharmaceutics Branch, directed R&D programs in medicinal chemistry, GMP synthesis, pharmacokinetics, analytical chemistry and other pharmaceutics aspects of medications development. Thirty two years of experience in NIDA and two years at the National Institute of Mental Health. Joined DTR&D in 1989.
James Glass, M.S., Chief, Informatics Program
301-443-1112
jg96y@nih.gov
Formulates and manages an informatics program supporting discovery, clinical, and regulatory programs. Thirty-nine years of experience in drug abuse treatment and prevention field, the past twenty-eight years with NIDA. Joined DTR&D in 1993.
Aida M. Klun, M.B.A., Program Analyst and Technology Transfer Coordinator
301-443-1122
ak102w@nih.gov
Plans, coordinates, and executes the administrative and managerial aspects of the Division. Assists the Director, DPMCDA with special research and analysis projects, personnel management, project management and strategic planning, procurement, space and property management, special events, presentations, special projects, operations and clinical trial budgets, technology transfer and other business-related interactions with private industry and academia, in support of divisional planning and evaluation activities. Joined DPMCDA in 1997.
Office of the Director
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
National Institute on Drug Abuse
6001 Executive Boulevard
Room 4123, MSC 9551
Bethesda, MD 20892-9551
(301) 443-6173 (phone)
(301) 443-2599 (fax)
|
|
DPMCDA Index
About NIDA Contents
|
|
